Therapy & Research
WHAT’S NEW
Psychedelic Science 2025: Set and (Re)Setting
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and...
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
POPULAR ARTICLES
Cannabis May Ease Opioid Withdrawal Symptoms, Johns Hopkins Study Finds
Researchers are calling for formal clinical trials into the efficacy of marijuana for treating opioid use disorder after a newly p...
Read More
Survey Of Psychiatrists Shows ‘Striking Positive Shift’ In Attitudes Toward Psychedelics Over Past 7 Years
More than 80 percent of surveyed psychiatrists now hold strong to moderate beliefs that psychedelics have potential to treat menta...
Read More
Psychedelics change how we see the world. A UC Berkeley study aims to find out why.
Researchers will use neuroimaging to observe the effects of psilocybin on the human brain — in real-time....
Read More
What Are Psilocybin Derivatives?
There are many compounds closely resembling psilocybin from a chemical structure standpoint. However, the chemical and pharmacolog...
Read More
Study Aims To Determine Role of Shrooms in Battling Alcoholism
University of Calgary researchers in Canada set out to investigate the role of psilocybin in battling alcohol use disorder....
Read More
Let’s Talk About Compass And Psychedelic Capitalism: Interview with Rick Doblin
Rick Doblin of MAPS sits down with Wesley Thoricatha to discuss Compass, for-profit psilocybin, and the emerging landscape of psyc...
Read More